{"id":987501797,"date":"2025-12-05T13:24:26","date_gmt":"2025-12-05T13:24:26","guid":{"rendered":"https:\/\/boracdmo.com\/bora-pharmaceuticals-marks-five-years-in-mississauga-canada-strengthening-its-commitment-to-onshore-and-global-cdmo-excellence\/?lang=en"},"modified":"2026-03-16T20:26:17","modified_gmt":"2026-03-16T20:26:17","slug":"bora-pharmaceuticals-marks-five-years-in-mississauga-canada-strengthening-its-commitment-to-onshore-and-global-cdmo-excellence","status":"publish","type":"post","link":"https:\/\/boracdmo.com\/bora-pharmaceuticals-marks-five-years-in-mississauga-canada-strengthening-its-commitment-to-onshore-and-global-cdmo-excellence\/","title":{"rendered":"Bora Pharmaceuticals Marks Five Years in Mississauga, Canada, Strengthening Its Commitment to Onshore and Global CDMO Excellence\u00a0"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"987501797\" class=\"elementor elementor-987501797\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ba94fb e-flex e-con-boxed e-con e-parent\" data-id=\"6ba94fb\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4750f35a elementor-widget elementor-widget-text-editor\" data-id=\"4750f35a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"has-text-align-center\"><em>Milestone reflects the company\u2019s continued impact in providing global pharmaceutical partners with reliable supply and enabling sustained patient access to life-saving therapies<\/em>\u00a0<\/h3><p class=\"has-text-align-center\">\u00a0<\/p><p class=\"has-text-align-center\">\u00a0<\/p><p><strong>Mississauga, Ontario (December 5, 2025) \u2013<\/strong>\u202f<a href=\"https:\/\/boracdmo.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Bora Pharmaceuticals Co., Ltd.<\/a> (\u201cBora\u201d or \u201cthe Company\u201d, TWSE: 6472), a global leader in pharmaceutical manufacturing, today celebrates the five-year anniversary of its Mississauga, Ontario, Canada facility, a key hub in the company\u2019s North American operations and a cornerstone of its expanding international CDMO network. The milestone will be celebrated onsite with employees, partners, and community stakeholders.\u00a0<\/p><p>\u00a0<\/p><p>Bora\u2019s Mississauga facility, its North American headquarters, spans 170,000 square meters\u202fand was purpose-built for flexible, high-quality, cGMP drug manufacturing. Equipped with 18 highly configurable manufacturing modules, the site provides \u201cbest-fit\u201d capabilities across development, manufacturing, packaging, and commercialization to support a wide range of prescription (Rx) and over-the-counter (OTC) oral solid dose (OSD), liquid, and semi-solid therapeutics. Bora recently announced a recent investment to install a <a href=\"https:\/\/boracdmo.com\/bora-pharmaceuticals-adds-new-filling-line-to-canadian-manufacturing-facility\/\" target=\"_blank\" rel=\"noreferrer noopener\">high-performance filling line<\/a> from Norden Machinery, enabling larger volumes at higher speeds with great flexibility, especially for dermatologic products.\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p>\u201cBora\u2019s Mississauga facility is more than a manufacturing site, it\u2019s a highly skilled community of professionals advancing Canada\u2019s life sciences ecosystem,\u201d said J.D. Mowery, President, Bora Pharmaceuticals CDMO division. \u201cWe are proud of the growth, innovation, and customer value this team delivers every day. Their expertise and dedication enable reliable global supply, accelerates patient access to essential medicines, and strengthens Bora\u2019s position as a trusted global CDMO partner. We\u2019re thrilled to celebrate this five-year milestone with the Bora team.\u201d\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p>Over the past five years, Bora\u2019s Mississauga site has become a vital anchor within Ontario\u2019s growing life sciences ecosystem, creating jobs, expanding technical training opportunities, and generating direct and indirect economic impact for the region.\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p>Since joining the Bora network in 2020, the facility has expanded both its technical capabilities and its customer base, becoming a strategic manufacturing partner for leading global pharmaceutical companies. Significant investments in new equipment and flexible manufacturing technologies have enabled the site to support 32 clients, advance 61 products, and deliver 60 development and technology-transfer projects, completing more than 400 project and development batches. These milestones reflect Mississauga\u2019s growing role in ensuring high-quality, cGMP production and reliable delivery for critical drug programs worldwide.\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p>\u201cCongratulations to the Mississauga team on five impactful years as part of the Bora network,\u201d said Gyan Singh, Senior Vice President of Operations at Azurity Pharmaceuticals. \u201cThe team consistently delivers on their commitments with high quality and technical excellence, making Bora a trusted and valued partner in Azurity\u2019s journey.\u201d\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p>\u201cBehind every milestone are the employees whose expertise brings Bora\u2019s mission to life,\u201d said John Lawrie, VP of Operations for Bora Pharmaceuticals. \u201cTheir commitment to quality, safety, and proactive customer support is what makes Mississauga a model of operational excellence within Bora\u2019s global network.\u201d\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p>The Mississauga site is one of seven\u202fcGMP Bora manufacturing facilities across the United States, Canada, and Taiwan that together form a rapidly expanding CDMO platform and deliver drug products to more than 100 countries. The company continues to invest in its global network to meet rising demand for high-quality, flexible pharmaceutical development and commercial manufacturing services.\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p># # #\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p><strong>About Bora Pharmaceuticals<\/strong>\u00a0<\/p><p>\u00a0<\/p><p>\u00a0<\/p><p><strong>Bora Pharmaceuticals<\/strong> is a premier international contract development and manufacturing organization (CDMO) specializing in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, biologic, and sterile injectable pharmaceutical products. From its world-class sites in North America and Asia, Bora delivers drug products with unparalleled quality to more than 100 markets around the world. Bora Pharmaceuticals Co., Ltd. is publicly traded on the Taiwan Stock Exchange (TWSE: 6472). For more information, visit <a href=\"https:\/\/www.boracdmo.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">www.boracdmo.com<\/a>.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Milestone reflects the company\u2019s continued impact in providing global pharmaceutical partners with reliable supply and enabling sustained patient access to life-saving therapies\u00a0 \u00a0 \u00a0 Mississauga, Ontario (December 5, 2025) \u2013\u202fBora Pharmaceuticals Co., Ltd. (\u201cBora\u201d or \u201cthe Company\u201d, TWSE: 6472), a global leader in pharmaceutical manufacturing, today celebrates the five-year anniversary of its Mississauga, Ontario, Canada [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":987501798,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[58],"tags":[],"class_list":["post-987501797","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business"],"aioseo_notices":[],"acf":[],"_links":{"self":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/987501797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/comments?post=987501797"}],"version-history":[{"count":3,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/987501797\/revisions"}],"predecessor-version":[{"id":987501802,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/987501797\/revisions\/987501802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/media\/987501798"}],"wp:attachment":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/media?parent=987501797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/categories?post=987501797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/tags?post=987501797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}